Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis-Reference-Cited by-同舟云学术

Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis

Published:2019-03-01 Issue:3 Volume:155 Page:327
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Yan Kexiang¹,Zhang Yuanjing²,Han Ling¹,Huang Qiong¹,Zhang Zhenghua¹,Fang Xu¹,Zheng Zhizhong¹,Yawalkar Nikhil³,Chang Yuling²,Zhang Qun²,Jin Ling²,Qian Danfeng²,Li Xueying²,Wu Mingshun²,Xu Qiaohu²,Zhang Xuejun¹,Xu Jinhua¹

Affiliation:

1. Shanghai Institute of Dermatology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China

2. Institute of Dermatology, Department of Dermatology, First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China

3. Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

http:///jamadermatology/article-pdf/155/3/327/17393165/jamadermatology_yan_2019_oi_180079.pdf

Reference35 articles.

1. Psoriasis.;Nestle;N Engl J Med,2009

2. Prevalence of psoriasis in China: a population-based study in six cities.;Ding;Eur J Dermatol,2012

3. The psoriasis drugs market.;Rizvi;Nat Rev Drug Discov,2015

4. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey.;Lebwohl;Am J Clin Dermatol,2016

5. Methotrexate: an old new drug in autoimmune disease.;Cipriani;Expert Rev Clin Immunol,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metagenomics reveals unique gut mycobiome biomarkers in psoriasis;Skin Research and Technology;2024-07

2. Identification of an exosomal miRNA-mRNA regulatory network contributing to methotrexate efficacy;International Immunopharmacology;2024-06

3. Gentiopicrin-Loaded Chitosan Nanoparticles as a Topical Agent for the Treatment of Psoriasis;Nanomaterials;2024-03-29

4. Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis;Medical Science Monitor;2024-03-12

5. Unlocking the role of the B7‐H4 polymorphism in psoriasis: Insights into methotrexate treatment outcomes: A prospective cohort study;Immunology;2023-10-09